Peter Osin

4.5k total citations · 3 hit papers
39 papers, 2.8k citations indexed

About

Peter Osin is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Peter Osin has authored 39 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cancer Research, 18 papers in Pathology and Forensic Medicine and 15 papers in Oncology. Recurrent topics in Peter Osin's work include Breast Cancer Treatment Studies (15 papers), Breast Lesions and Carcinomas (13 papers) and Cancer Genomics and Diagnostics (9 papers). Peter Osin is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Breast Lesions and Carcinomas (13 papers) and Cancer Genomics and Diagnostics (9 papers). Peter Osin collaborates with scholars based in United Kingdom, United States and Canada. Peter Osin's co-authors include Ashutosh Nerurkar, Ian E. Smith, Mitch Dowsett, Nicholas C. Turner, Gaia Schiavon, Isaac García-Murillas, Sunil R. Lakhani, Douglas F. Easton, Lesley McGuffog and Jocelyne Jacquemier and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Peter Osin

39 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

2015 814 citations Peter Osin, Ashutosh Nerurkar et al. profile →
The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2

2002 614 citations Sunil R. Lakhani, Marc J. van de Vijver et al. Journal of Clinical Oncology profile →
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer

2015 416 citations Elena López‐Knowles, Ricardo Ribas et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Osin United Kingdom	15	1.8k	1.3k	1.1k	802	735	39	2.8k
Fujio Kasumi Japan	30	1.3k 0.7×	1.4k 1.0×	1.4k 1.3×	790 1.0×	370 0.5×	122	3.4k
Étienne Rouleau France	28	1.1k 0.6×	1.1k 0.8×	1.2k 1.2×	561 0.7×	644 0.9×	110	2.7k
Gavin Ha United States	22	1.6k 0.9×	951 0.7×	1.7k 1.6×	489 0.6×	688 0.9×	54	3.3k
Mark Sausen United States	20	1.8k 1.0×	1.2k 0.9×	1.2k 1.2×	245 0.3×	921 1.3×	51	3.1k
Kerry Fenwick United Kingdom	38	1.9k 1.0×	2.2k 1.6×	2.8k 2.6×	850 1.1×	1.1k 1.5×	60	4.9k
Rebecca Leary United States	11	2.6k 1.4×	1.7k 1.3×	2.0k 1.9×	367 0.5×	716 1.0×	18	4.0k
Ashutosh Nerurkar United Kingdom	15	1.6k 0.9×	1.2k 0.9×	757 0.7×	320 0.4×	712 1.0×	42	2.3k
Maryou B. Lambros United Kingdom	31	1.3k 0.8×	1.4k 1.1×	1.6k 1.5×	384 0.5×	460 0.6×	45	3.2k
Véronique Becette France	18	983 0.6×	1.0k 0.8×	889 0.8×	281 0.4×	412 0.6×	56	2.2k
Leticia De Mattos‐Arruda Spain	26	1.4k 0.8×	1.3k 1.0×	947 0.9×	159 0.2×	735 1.0×	54	2.7k

Countries citing papers authored by Peter Osin

Since Specialization

Citations

This map shows the geographic impact of Peter Osin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Osin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Osin more than expected).

Fields of papers citing papers by Peter Osin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Osin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Osin. The network helps show where Peter Osin may publish in the future.

Co-authorship network of co-authors of Peter Osin

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Osin. A scholar is included among the top collaborators of Peter Osin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Osin. Peter Osin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Okines, Alicia, Kabir Mohammed, Peter Osin, et al.. (2022). Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience. Breast Cancer Research and Treatment. 192(3). 563–571. 3 indexed citations

Gui, Gerald, Sarah Tang, Dominique Twelves, et al.. (2021). The INTEND 1 randomized controlled trial of duct endoscopy as an indicator of margin excision in breast conservation surgery. Breast Cancer Research and Treatment. 186(3). 723–730. 1 indexed citations

Osin, Peter, Ashutosh Nerurkar, Ian C. P. Smith, et al.. (2019). Clinical Outcomes in Triple-negative Lobular Breast Cancer: a Single-institution Experience. Clinical Oncology. 31(7). e110–e110. 1 indexed citations

López‐Knowles, Elena, Paul M Wilkerson, Ricardo Ribas, et al.. (2015). Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer. Breast Cancer Research. 17(1). 35–35. 7 indexed citations

Allen, Steven, et al.. (2014). The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years. European Journal of Surgical Oncology. 40(7). 824–829. 11 indexed citations

Dunbier, Anita K., Zara Ghazoui, H Anderson, et al.. (2013). Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance. Clinical Cancer Research. 19(10). 2775–2786. 98 indexed citations

Twelves, Dominique, Ashutosh Nerurkar, Peter Osin, et al.. (2013). DNA promoter hypermethylation profiles in breast duct fluid. Breast Cancer Research and Treatment. 139(2). 341–350. 15 indexed citations

Twelves, Dominique, Ashutosh Nerurkar, Peter Osin, et al.. (2012). The feasibility of nipple aspiration and duct lavage to evaluate the breast duct epithelium of women with increased breast cancer risk. European Journal of Cancer. 49(1). 65–71. 11 indexed citations

Twelves, Dominique, Ashutosh Nerurkar, Peter Osin, et al.. (2011). The anatomy of fluid-yielding ducts in breast cancer. Breast Cancer Research and Treatment. 132(2). 555–564. 6 indexed citations

10.

MacNeill, Fiona, Janine Salter, Simone Detre, et al.. (2010). Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer. Breast Cancer Research. 12(5). R76–R76. 103 indexed citations

11.

Hegyi, László, Khin Thway, Robert Newton, et al.. (2009). Malignant myoepithelioma arising in adenomyoepithelioma of the breast and coincident multiple gastrointestinal stromal tumours in a patient with neurofibromatosis type 1. Journal of Clinical Pathology. 62(7). 653–655. 10 indexed citations

12.

Arnedos, Mónica, Ashutosh Nerurkar, Peter Osin, et al.. (2009). Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Annals of Oncology. 20(12). 1948–1952. 142 indexed citations

13.

Gui, Gerald, Ann Ward, Sunil R. Lakhani, et al.. (2005). Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer. European Journal of Surgical Oncology. 31(7). 707–714. 14 indexed citations

14.

Gui, Gerald, Kasim A. Behranwala, N Abdullah, et al.. (2004). The inframammary fold: contents, clinical significance and implications for immediate breast reconstruction. British Journal of Plastic Surgery. 57(2). 146–149. 23 indexed citations

15.

Nerurkar, Ashutosh & Peter Osin. (2003). The diagnosis and management of pre-invasive breast disease: The role of new diagnostic techniques. Breast Cancer Research. 5(6). 305–8. 10 indexed citations

16.

Sullivan, Alexandra, Martin Yuille, Claire E. Repellin, et al.. (2002). Concomitant inactivation of p53 and Chk2 in breast cancer. Oncogene. 21(9). 1316–1324. 67 indexed citations

17.

Lakhani, Sunil R., Marc J. van de Vijver, Jocelyne Jacquemier, et al.. (2002). The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2. Journal of Clinical Oncology. 20(9). 2310–2318. 614 indexed citations breakdown →

18.

Osin, Peter, Janet Shipley, Yong‐Jie Lu, Tim Crook, & B.A. Gusterson. (1998). Experimental Pathology and Breast Cancer Genetics: New Technologies. Recent results in cancer research. 152. 35–48. 19 indexed citations

19.

Osin, Peter, et al.. (1998). Breast development gives insights into breast disease. Histopathology. 33(3). 275–283. 17 indexed citations

20.

Osin, Peter, Eitan Shiloni, Alon J. Pikarsky, & E. Okon. (1996). Metastatic adenocarcinoma in a thyroid colloid nodule: A rare presentation of colon cancer. Pathology. 28(3). 236–237. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact